FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3207764260> ?p ?o ?g. }

• W3207764260 endingPage "264" @default.
• W3207764260 startingPage "258" @default.
• W3207764260 abstract "Diffuse large B cell lymphoma (DLBCL) is an aggressive but potentially curable malignancy; however, cure is highly dependent on the ability to deliver intensive, anthracycline-based chemoimmunotherapy. Nearly one third of cases of DLBCL occur in patients over age 75 years, and advanced age is an important adverse feature in prognostic models. Despite this incidence in older patients, there is no clear accepted standard of care due to under-representation of this group in large randomized clinical trials. Furthermore, insufficient assessments of baseline frailty and prediction of toxicity hamper clinical decision-making. Here, we present an ongoing randomized study of R-miniCHOP chemoimmunotherapy with or without oral azacitidine (CC-486, Onureg) for patients age 75 and older with newly diagnosed DLBCL and associated aggressive lymphomas. The incorporation of an oral hypomethylating agent is based on increased tumor methylation as a biologic feature of older patients with DLBCL and a desire to minimize the injection burden for this population. This is the first randomized study in this population conducted in North America by the National Clinical Trials Network (NCTN) and will enroll up to 422 patients including 40 patients in a safety run-in phase. This study incorporates an objective assessment of baseline frailty (the FIL Tool) and a serial comprehensive geriatric assessment (CGA). Key correlative tests will include circulating tumor DNA (ctDNA) assays at pre-specified timepoints to explore if ctDNA quantity and methylation patterns correlate with response. S1918 has the potential to impact future trial design and to change the standard of care for patients 75 years and older with aggressive lymphoma given its randomized design, prospective incorporation of geriatric assessments, and exploration of ctDNA correlatives.Trial registration: The trial is registered with ClinicalTrial.gov Identifier NCT04799275" @default.
• W3207764260 created "2021-10-25" @default.
• W3207764260 creator A5005159945 @default.
• W3207764260 creator A5007420876 @default.
• W3207764260 creator A5014919457 @default.
• W3207764260 creator A5016048836 @default.
• W3207764260 creator A5038526399 @default.
• W3207764260 creator A5040240883 @default.
• W3207764260 creator A5041539801 @default.
• W3207764260 creator A5041588764 @default.
• W3207764260 creator A5041975013 @default.
• W3207764260 creator A5050726526 @default.
• W3207764260 creator A5059389744 @default.
• W3207764260 creator A5063192858 @default.
• W3207764260 creator A5068817380 @default.
• W3207764260 creator A5086211539 @default.
• W3207764260 date "2022-03-01" @default.
• W3207764260 modified "2023-10-18" @default.
• W3207764260 title "SWOG 1918: A phase II/III randomized study of R-miniCHOP with or without oral azacitidine (CC-486) in participants age 75 years or older with newly diagnosed aggressive non-Hodgkin lymphomas – Aiming to improve therapy, outcomes, and validate a prospective frailty tool" @default.
• W3207764260 cites W2028311823 @default.
• W3207764260 cites W2056677678 @default.
• W3207764260 cites W2058015212 @default.
• W3207764260 cites W2106928992 @default.
• W3207764260 cites W2110489999 @default.
• W3207764260 cites W2115484783 @default.
• W3207764260 cites W2129827192 @default.
• W3207764260 cites W2131424155 @default.
• W3207764260 cites W2133159533 @default.
• W3207764260 cites W2136621779 @default.
• W3207764260 cites W2143505663 @default.
• W3207764260 cites W2145453495 @default.
• W3207764260 cites W2152124377 @default.
• W3207764260 cites W2156402672 @default.
• W3207764260 cites W2563063147 @default.
• W3207764260 cites W2600153453 @default.
• W3207764260 cites W2888203943 @default.
• W3207764260 cites W2909829613 @default.
• W3207764260 cites W2951995922 @default.
• W3207764260 cites W2955248709 @default.
• W3207764260 cites W2962478573 @default.
• W3207764260 cites W2979316304 @default.
• W3207764260 cites W3031372067 @default.
• W3207764260 cites W3094642003 @default.
• W3207764260 cites W3120715707 @default.
• W3207764260 cites W3127059308 @default.
• W3207764260 cites W3134894565 @default.
• W3207764260 doi "https://doi.org/10.1016/j.jgo.2021.10.003" @default.
• W3207764260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34686472" @default.
• W3207764260 hasPublicationYear "2022" @default.
• W3207764260 type Work @default.
• W3207764260 sameAs 3207764260 @default.
• W3207764260 citedByCount "7" @default.
• W3207764260 countsByYear W32077642602022 @default.
• W3207764260 countsByYear W32077642602023 @default.
• W3207764260 crossrefType "journal-article" @default.
• W3207764260 hasAuthorship W3207764260A5005159945 @default.
• W3207764260 hasAuthorship W3207764260A5007420876 @default.
• W3207764260 hasAuthorship W3207764260A5014919457 @default.
• W3207764260 hasAuthorship W3207764260A5016048836 @default.
• W3207764260 hasAuthorship W3207764260A5038526399 @default.
• W3207764260 hasAuthorship W3207764260A5040240883 @default.
• W3207764260 hasAuthorship W3207764260A5041539801 @default.
• W3207764260 hasAuthorship W3207764260A5041588764 @default.
• W3207764260 hasAuthorship W3207764260A5041975013 @default.
• W3207764260 hasAuthorship W3207764260A5050726526 @default.
• W3207764260 hasAuthorship W3207764260A5059389744 @default.
• W3207764260 hasAuthorship W3207764260A5063192858 @default.
• W3207764260 hasAuthorship W3207764260A5068817380 @default.
• W3207764260 hasAuthorship W3207764260A5086211539 @default.
• W3207764260 hasBestOaLocation W32077642601 @default.
• W3207764260 hasConcept C104317684 @default.
• W3207764260 hasConcept C126322002 @default.
• W3207764260 hasConcept C143998085 @default.
• W3207764260 hasConcept C150194340 @default.
• W3207764260 hasConcept C168563851 @default.
• W3207764260 hasConcept C185592680 @default.
• W3207764260 hasConcept C190727270 @default.
• W3207764260 hasConcept C197934379 @default.
• W3207764260 hasConcept C2776239401 @default.
• W3207764260 hasConcept C2778559949 @default.
• W3207764260 hasConcept C2779338263 @default.
• W3207764260 hasConcept C2780235182 @default.
• W3207764260 hasConcept C2780653079 @default.
• W3207764260 hasConcept C2780790343 @default.
• W3207764260 hasConcept C2908647359 @default.
• W3207764260 hasConcept C535046627 @default.
• W3207764260 hasConcept C55493867 @default.
• W3207764260 hasConcept C71924100 @default.
• W3207764260 hasConcept C99454951 @default.
• W3207764260 hasConceptScore W3207764260C104317684 @default.
• W3207764260 hasConceptScore W3207764260C126322002 @default.
• W3207764260 hasConceptScore W3207764260C143998085 @default.
• W3207764260 hasConceptScore W3207764260C150194340 @default.
• W3207764260 hasConceptScore W3207764260C168563851 @default.
• W3207764260 hasConceptScore W3207764260C185592680 @default.
• W3207764260 hasConceptScore W3207764260C190727270 @default.
• W3207764260 hasConceptScore W3207764260C197934379 @default.
• W3207764260 hasConceptScore W3207764260C2776239401 @default.

• next